Recently, organ support therapy for liver failure has made rapid progress in the direction of clearing bile acids, blood ammonia, and inflammatory factors. However, there is still a lack of high-level evidence-based medicine, necessitating extensive research on the pathogenesis of major subtypes of liver failure so as to explore collaborative key points of clinical research design decisions for appropriate organ support therapy.
肝衰竭的器官支持治疗手段近来进步较快，在清除胆汁酸、血氨及炎症因子等方面进展迅速。但高级别循证医学证据仍然欠缺，需要深入研究主要亚型肝衰竭的发病机制，并合作探索合适的器官支持治疗手段相关临床研究设计决策要点。.